Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children.
about
Hematopoietic stem cell transplantation for people with sickle cell diseaseHematopoietic stem cell transplantation for people with ß-thalassaemia majorHematopoietic stem cell transplantation for people with sickle cell diseaseStem cell transplantation for people with ß thalassaemia majorHematopoietic stem cell transplantation for people with ß-thalassaemia majorHematopoietic stem cell transplantation for children with sickle cell diseaseAlternative donor transplant of benign primary hematologic disordersUmbilical cord blood: an evolving stem cell source for sickle cell disease transplantsMinor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector functionHematopoietic stem cell transplantation for people with ß-thalassaemia major.Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy.Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions.Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapyHLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity.Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases.Cord blood stem cell transplantation for haemoglobinopathies.Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.Reduced-intensity conditioning in children: a reappraisal in 2008.Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model.Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood.Blood and marrow transplantation for sickle cell disease: overcoming barriers to success.A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies.Translational research and therapeutic applications of stem cell transplantation in periodontal regenerative medicine.The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.Blood and marrow transplantation for sickle cell disease: is less more?Bidirectional immune tolerance in nonmyeloablative MHC-mismatched BMT for murine β-thalassemia.Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.Hematopoietic stem cell transplantation for inborn errors of metabolism: A report from the Research Committee on Transplantation for Inborn Errors of Metabolism of the Japanese Ministry of Health, Labour and Welfare and the Working Group of the JapaComparison of second transplantation and donor lymphocyte infusion for donor mixed chimerism after allogeneic stem cell transplantation for nonmalignant diseases.Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.Second bone marrow transplantation for patients with thalassemia: risks and benefits.Hematopietic stem cell transplantation in thalassemia and related disorders.Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.Increased intensity of acute graft-versus-host disease after reduced-intensity bone marrow transplantation compared to conventional transplantation from an HLA-matched sibling in children.
P2860
Q24185759-42B80352-ACEA-41C2-931A-7A14F92DB1E6Q24193101-71FA2302-0BEE-4CA5-8E26-D415905D1B69Q24202852-FDD8494D-2AE4-4A6E-A260-55D2EA0939FAQ24235816-CF2F094B-E7A3-4121-B9E0-8F9FF0714049Q24236027-5C45150D-077C-40CD-AE2D-AC6F31B8020FQ24240994-196FB96C-14DB-4023-B811-E1C4337F2B9DQ26823398-CF6B4F5C-45DE-4D1B-94C5-B3FB61126549Q26853559-4014B303-4FA9-4D89-A163-649784679FDDQ28652702-89EE586E-3781-47E3-B838-4D26B78E8DDDQ34546216-B1B2809A-C082-4768-BA18-276E66967776Q35153756-7C52D841-8DA7-474B-BBDE-9B41637BB620Q35948568-5C3EBBF3-EE8E-4BFA-B4F0-4D5D35D8B553Q36027459-1517FF4F-6A96-4055-B84E-FAF42168D182Q36038875-61297443-6C07-4B67-80CB-B8111193CA61Q36059652-2D55C9CE-A1EC-4B8B-892C-4AE3820899C9Q36343931-E53F59D2-BB59-4537-8B7A-EB7884C8C055Q36425417-3FE40BE4-FF2D-40A0-9D0C-1830F6BE9CFCQ36577708-29A12D81-1060-4540-B5F0-55BFE5BE0FDBQ37014122-058984FE-6B03-44BA-B068-B838C82047FBQ37096984-3BA04F40-20ED-483F-8D83-A3B66FFD7590Q37154176-B6C4948B-4877-450E-B6E0-30E5AC61952EQ37188472-2ADD25F0-9C2E-4D8F-BFFD-570F90A001D1Q37351058-1E346248-F1FB-46BE-A1D0-60BCD16224D2Q37435417-FB02909C-1887-49B7-A283-AB4AFD4B8399Q37521563-D1612E14-3543-477F-AD4A-889BBBC0C9F9Q37627281-9F480642-EF36-499D-BC1F-0A004AC74416Q37721514-CE786B58-3DD8-4F11-BB8F-8B47B9909463Q37990549-677D803F-CF00-4D15-BDC7-A387358F1BBFQ38048961-6B631118-BDB3-465D-8D01-B4DD6F6914DBQ38176054-9EF4CD36-C521-4642-96C6-F54823D276AFQ38248808-48827AB6-A2C6-47A3-BBAC-8848027A477FQ38870274-31D693FC-7E35-48B2-939E-E40067501279Q39705843-8139851D-4015-4097-A736-7C4C57187A66Q40066114-7E6FACE8-FE67-4AD4-904F-754131B10E02Q40533264-8469BCAE-6585-465E-9402-DCE851AACDCBQ41010661-C6726DA8-F703-4DB7-92CF-6AFDF44776E5Q42547435-54257F1B-3EAF-4847-87EF-BF62B73C4AD9Q42588942-1AE2EE93-1314-4AC6-88F9-8E3CCE6FCC04Q44037646-A9BA3351-7EA0-4960-BEF1-C1B5E2ABF56FQ44499717-BBAD0D76-C375-4395-81BF-D383B7E5A3CF
P2860
Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Reduced intensity haemopoietic ...... alignant diseases in children.
@en
Reduced intensity haemopoietic ...... alignant diseases in children.
@nl
type
label
Reduced intensity haemopoietic ...... alignant diseases in children.
@en
Reduced intensity haemopoietic ...... alignant diseases in children.
@nl
prefLabel
Reduced intensity haemopoietic ...... alignant diseases in children.
@en
Reduced intensity haemopoietic ...... alignant diseases in children.
@nl
P2093
P1433
P1476
Reduced intensity haemopoietic ...... alignant diseases in children.
@en
P2093
David A Jacobsohn
Morris Kletzel
Reggie Duerst
William Tse
P304
P356
10.1016/S0140-6736(04)16628-2
P407
P577
2004-07-01T00:00:00Z